XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Note 11 - Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2025
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Three Months Ended March 31,

 
  

2025

  

2024

 

Revenue

 $20,876  $2,181 

Less:

        

Research and development

        

External program costs:

        

Norovirus program

  1,556   1,002 

COVID-19 program

  15,718   2,963 

Other programs

  306    

Preclinical research

  399   723 

Process Development

  46   35 

Internal research and development costs

  12,719   14,290 

General and administrative

  5,067   7,238 

Interest income

  (437)  (503)

Non-cash interest expense related to sale of future royalties

  997   804 

Other segment items(A)

  1   1 

Provision for income taxes

  95   45 

Segment net loss

 $(15,591) $(24,417)

Reconciliation of net loss

        

Adjustments and reconciling items

      

Net loss

 $(15,591) $(24,417)